Malignant Ascites Market to Observe Growth at a CAGR of 1.2% by 2034 | DelveInsight [Yahoo! Finance]
PharmaCyte Biotech, Inc. (PMCB)
NASDAQ:AMEX Investor Relations:
ir.pharmacytebiotech.com
Company Research
Source: Yahoo! Finance
The major key players include Clover Biopharmaceuticals and Wuhan YZY Biopharma which hold the potential to create a significant positive shift in the malignant ascites market size. LAS VEGAS April 29, 2024 /PRNewswire/ -- DelveInsight's Malignant Ascites Market Insights report includes a comprehensive understanding of current treatment practices, malignant ascites emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into 7MM [ the United States , the EU4 ( Germany France Italy , and Spain ) and the United Kingdom , and Japan ]. Key Takeaways from the Malignant Ascites Market Report According to DelveInsight's analysis, the market size for malignant ascites reached USD 1.9 billion in 2020 across the 7MM, which is anticipated to rise to USD 2.3 billion by 2034. In 2020, the total incident cases of malignant ascites-associated cancers were ~1.6 million in the 7MM. Leading malignant ascites companies such as L
Show less
Read more
Impact Snapshot
Event Time:
PMCB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PMCB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PMCB alerts
High impacting PharmaCyte Biotech, Inc. news events
Weekly update
A roundup of the hottest topics
PMCB
Sec Filings
- 5/1/24 - Form 8-K
- 3/27/24 - Form ARS
- 3/27/24 - Form DEF
- PMCB's page on the SEC website